✦ LIBER ✦

Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase–producing Escherichia coli or Klebsiella pneumoniae

✍ Scribed by Nan-Yao Lee; Wei-Han Huang; Ko-Chung Tsui; Po-Ren Hsueh; Wen-Chien Ko

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carbapenem therapy for bacteremia due to

✍ P.-R. Hsueh; W.-C. Ko 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Clinical manifestations and prognostic f

✍ Shu-Shen Wang; Nan-Yao Lee; Po-Ren Hsueh; Wei-Han Huang; Ko-Chung Tsui; Hsin-Chu 📂 Article 📅 2011 🏛 Scientific Communications 🌐 English ⚖ 244 KB

Therapeutic Challenges Associated with E

✍ Annie Wong-Beringer 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Piperacillin–tazobactam as an initial em

✍ Cheol-In Kang; So Yeon Park; Doo Ryeon Chung; Kyong Ran Peck; Jae-Hoon Song 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Genetic evolution and clinical impact in

✍ Yong Chong; Yoshikiyo Ito; Tomohiko Kamimura 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Emergence of carbapenem resistance due t

✍ D.P. Webster; T. Gaulton; N. Woodford; R. Pike; J. Turton; C. Perry; I.C.J.W. Bo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 103 KB